The estimates range from $13.5 trillion to $47.6 trillion. The variables include the generosity of the benefit and forecasts for reining in health care expenditures.
Insurers, employers, and telehealth vendors are offering attractive new options for seeing the doctor without leaving home. But some of these programs may be used as an iffy substitute for health insurance, and the savings they can achieve remains uncertain.
In 2020, eight companies in the National Drug Purchasing Coalition hope to change how PBMs do business.
A Conversation with John Woolley, President and Ceo, Hatfield Medical Group
Restrictions blunted the effect of Sovaldi and other antivirals on Medicaid budgets. The gradual removal of these barriers is going too slowly, say advocates.
As genetic testing gets more costly and complex, health plans call on yet another intermediary for help in curbing excessive utilization. But is adding a new middleman really the answer?
But discontinuation rate is high, and Wall Street is unimpressed by sales of the new class of migraine medications.